Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands,
Eur J Epidemiol. 2014 Nov;29(11):841-50. doi: 10.1007/s10654-014-9951-y. Epub 2014 Sep 12.
When studying the causal effect of drug use in observational data, marginal structural modeling (MSM) can be used to adjust for time-dependent confounders that are affected by previous treatment. The objective of this study was to compare traditional Cox proportional hazard models (with and without time-dependent covariates) with MSM to study causal effects of time-dependent drug use. The example of primary prevention of cardiovascular disease (CVD) with statins was examined using up to 17.7 years of follow-up from 4,654 participants of the observational prospective population-based Rotterdam Study. In the MSM model, the weight was based on measurements of established cardiovascular risk factors and co-morbidity. In general, we could not demonstrate important differences in results from the Cox models and MSM. Results from analysis on duration of statin use suggested that substantial residual confounding by indication was not accounted for during the period shortly after statin initiation. In conclusion, although on theoretical grounds MSM is an elegant technique, lack of data on the precise time-dependent confounders, such as indication of treatment or other considerations of the prescribing physician jeopardizes the calculation of valid weights. Confounding remains a hurdle in observational effectiveness research on preventive drugs with a multitude of prescription determinants.
当在观察性数据中研究药物使用的因果效应时,可以使用边缘结构模型(MSM)来调整受先前治疗影响的时变混杂因素。本研究的目的是比较传统的 Cox 比例风险模型(有和无时变协变量)与 MSM,以研究时变药物使用的因果效应。使用前瞻性观察性基于人群的鹿特丹研究中 4654 名参与者的长达 17.7 年的随访数据,考察了他汀类药物在心血管疾病(CVD)一级预防中的作用。在 MSM 模型中,权重基于已建立的心血管风险因素和合并症的测量值。一般来说,我们不能证明 Cox 模型和 MSM 的结果存在重要差异。他汀类药物使用持续时间分析的结果表明,在他汀类药物起始后不久的时期内,指示性残余混杂因素未得到充分考虑。总之,尽管从理论上讲,MSM 是一种优雅的技术,但缺乏关于确切的时变混杂因素的数据,例如治疗的指示或处方医生的其他考虑因素,这会危及有效权重的计算。混杂因素仍然是具有多种处方决定因素的预防性药物观察性效果研究中的一个障碍。